Update on pancreatic cancer research in Australia and around the globe.
Sofia Casbolt
Program Manager
Michelle Stewart
Chief Executive Officer, PanKind
Michelle joined PanKind, The Australian Pancreatic Cancer Foundation in August 2019. With a background in medical research funding, foreign investment attraction, digital health and international clinical trials, she has spent many years working across global, transformational projects. Michelle was a key member of the team that transformed the research funding environment for brain cancer from ‘forgotten cancer’ to national health priority in the capacity of Head of Research Strategy and then CEO. Michelle has served on many committees including advisory to Cancer Australia for the Australian Brain Cancer Mission, the Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) and was Co-Chair of the Global Patient Advocacy Committee for GBM AGILE. Michelle holds a Bachelor of Advanced Science and Masters of Public Health, both from The University of Sydney. Michelle is a member of the Australian Institute of Company Directors.
Prof Ross McKinnon
Chair, PanKind Scientific Advisory Panel
B Sci (Hons), PhD, FFIP, FGLF, FAHMS, MAIC
Professor Ross McKinnon is Matthew Flinders Distinguished Professor and Beat Cancer Professorial Fellow in the College of Medicine and Public Health at Flinders University. He was formerly Dean (Research) and Foundation Director of the Flinders Health and Medical Research Institute. He is also currently Chair of the Board of Pharmaceutical Sciences in the International Pharmaceutical Federation (FIP). As an academic pharmacist, Ross has broad research interests in the pharmacology, pharmaceutical biotechnology and molecular oncology areas.